Kirkland & Ellis advised LYFE Capital, one of the leading China-focused healthcare sponsors, in the fundraising of its third USD healthcare fund at its hard cap of US$550 million in a one and final closing. The fund was oversubscribed with a broad mix of global institutional investors, including sovereigns, pensions, endowments, foundations, banks, family offices and fund of funds investors.

The Kirkland team was led by investment funds partners Carol Liu and Liyong Xing, and included international trade & national security partner Mario Mancuso, investment funds partner Josh Westerholm, tax partner Alec Campbell, government and internal investigations partner Nick Niles, and employee benefits partner Elizabeth Dyer and of counsel Christine Matott.